Vera Bradley Q1 revenue $55.7M (+7.8% YoY); operating loss improves 74%

Vera Bradley, Inc.

Net loss from continuing ops ($4.8M), or ($0.17) diluted EPS; non-GAAP loss ($0.09).
Direct segment revenues $44.9M (+4.1%); comparable sales +13.4%. Indirect revenues $26.6%.
Consolidated gross margin 51.8%, up 770 bps YoY (non-GAAP 430 bps). SG&A down 16%.
Inventory reduced 26% to $73.0M; no borrowings on ABL. Cash $12.5M.
FY27 guidance: sales $255M-$270M; operating loss improvement now at least 50% vs prior loss of ($21.7M).

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Vera Bradley, Inc. reported the first quarter of the fiscal year ending January 30, 2027 ("Fiscal 2027") results: revenue $55.7 million, net income net loss from continuing operations totaled ($4.8) million, or ($0.17) per diluted share, EPS ($0.17) per diluted share. Guidance raised.

Period: the first quarter of the fiscal year ending January 30, 2027 ("Fiscal 2027")
Revenue: $55.7 million
Net income: net loss from continuing operations totaled ($4.8) million, or ($0.17) per diluted share
EPS: ($0.17) per diluted share
Guidance: raised
Result: reported results

Exact text from the filing

as Exhibit 99.1 to this report. --- EX-99.1 (EX-99.1) --- VERA BRADLEY ANNOUNCES FIRST QUARTER FISCAL YEAR 2027 RESULTS First quarter consolidated net revenues grew 7.8% to $55.7 million; represents the first quarter of growth since Fiscal 2022 Continued sequential progress with sales growth, margin expansion and significant profit improvement FORT WAYNE, Ind.,

View on SEC.gov

309 earnings releases filed in the last 30 days. Browse all earnings releases →

Vera Bradley, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-042374

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.